在患有非传染性疾病的老年患者中,疾病恶化的风险感知:潜伏性个人资料分析
Jizhe Wang1, Xiaohong Lu1, Xinyang Yu1
1The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.
概括
患有慢性疾病的老年患者表现出不同的风险感知概况. 干预措施应根据这些概况进行个性化,考虑性别,教育,年龄和保险等因素,以加强疾病管理.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 健康心理学 心理健康心理学
背景情况:
- 患有非传染性疾病 (NCD) 的老年人在疾病管理方面面临着独特的挑战.
- 对疾病恶化的准确风险感知对于坚持治疗和自我管理至关重要.
- 了解这一群体中不同风险感知特征对于有针对性的干预措施至关重要.
研究的目的:
- 确定与NCDs的老年患者疾病恶化有关的风险感知的明显隐性概况.
- 确定影响这些已识别的风险感知概况的关键人口和临床因素.
主要方法:
- 方便抽样招募了598名患有非传染性疾病的老年患者.
- 隐性概况分析 (LPA) 用于识别不同的风险感知概况.
- 多变量无序逻辑回归分析检查了每个配置文件的影响因素.
主要成果:
- 结果发现了四种不同的潜形状:形状1 (较高的风险感知 - 较低的情感体验),形状2 (中等风险感知),形状3 (较低的风险感知) 和形状4 (较高的风险感知 - 更严重的结果).
- 概况1与男性性别和更长的疾病持续时间有关.
- 个人资料3与较低的教育程度 (小学或更低) 有关.
- 个人资料4与年龄较大,特定的医疗保险报销比例 (<30%或30%-50%) 和更长的疾病持续时间有关.
结论:
- 在患有非传染性疾病的老年患者中,存在与疾病恶化有关的风险感知特征.
- 诸如性别,年龄,教育,诊断后的时间和医疗保险退款等因素会影响这些情况.
- 根据特定风险感知概况量身定制的个性化干预措施可能会改善疾病管理和结果.
更多相关视频
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
Factors Affecting Illness
5.0K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
5.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
224
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
224
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
233
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
233
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
228
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
228


